Abstract
In studies on antitumor antibody-cytotoxic drug conjugates as potential tumor-selective cytotoxic agents, methotrexate (MTX) was conjugated via its active ester derivative with a murine monoclonal antibody (aMM46) to a mouse mammary tumor antigen (MM antigen) on syngeneic, ascitic C3H/He mouse mammary tumor MM46 cells. The conjugate retained full antibody activity, as assayed by complement-dependent cytolysis. The target-selective cytotoxicity of aMM46-MTX was verified by the observations that this conjugate showed greater cytotoxicity than the corresponding normal mouse immunoglobulin (nIg) conjugate to MM46 cells, neither aMM46 nor nIg being cytotoxic, and that it showed less cytotoxicity to MM antigen negative mouse mammary tumor MM48 cells than to MM46 cells, its cytotoxicity to MM48 cells being similar to that of the nIg conjugate. From the results of assays of cell binding and uptake of 131I-labeled aMM46 and aMM46-3H-MTX, aMM46 and aMM46-MTX were internalized after their binding to MM46 cell surface antigen. Leupeptin, an inhibitor of the lysosomal endopeptidase cathepsin, decreased the cytotoxicity of aMM46-MTX, supporting the involvement of lysosomal degradation of the conjugate in its action.
Keywords: Methotrexate, Tumor Antigen, Endopeptidase, Active Ester, Cell Surface Antigen
References
- 1.Blair AH, Ghose TI. Linkage of cytotoxic agents to immunoglobulins. J Immunol Methods. 1983;59:129. doi: 10.1016/0022-1759(83)90024-8. [DOI] [PubMed] [Google Scholar]
- 2.Bradford NM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
- 3.Ehrlich P. Chemotherapy. In: Himmelweit F, editor. The collected papers of Paul Ehrlich, vol III. London: Pergamon Press; 1913. p. 510. [Google Scholar]
- 4.Embleton MJ, Garnett MC. Antibody targeting of anticancer agents. In: Baldwin RW, Byers VS, editors. Monoclonal antibodies for cancer detection and therapy. New York: Academic Press; 1985. p. 317. [Google Scholar]
- 5.Garnett MC, Baldwin RW. An improved synthesis of a methotrexate-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines. Cancer Res. 1986;46:2407. [PubMed] [Google Scholar]
- 6.Garnett MC, Embleton MJ, Jacobs E, Baldwin RW. Preparation and properties of a drug carrier antibody conjugate showing selective antibody-directed cytotoxicity in vitro. Int J Cancer. 1983;31:661. doi: 10.1002/ijc.2910310520. [DOI] [PubMed] [Google Scholar]
- 7.Ghose T, Blair AH. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects. J Natl Cancer Inst. 1978;61:657. [PubMed] [Google Scholar]
- 8.Halpern SE, Hagan PL, Garver PR, Koziol JA, Chen AWN, Frincke JM, Bartholomew RM, David GS, Adams TH. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse human tumor models. Cancer Res. 1983;43:5347. [PubMed] [Google Scholar]
- 9.Huang A, Kennel SJ, Huang L. Interactions of immunoliposomes with target cells. J Biol Chem. 1983;258:14034. [PubMed] [Google Scholar]
- 10.Irie RF. Antigenic cross-reactivity between primary spontaneous mouse mammary tumors and their transplantable ascites tumors. Cancer Res. 1971;31:1682. [PubMed] [Google Scholar]
- 11.Irie RF, Nishioka K, Tachibana T, Takeuchi S. Immunological studies on mouse mammary tumors. IV. Extraction and solubilization of transplantation antigen of mouse mammary tumor. Int J Cancer. 1969;4:150. doi: 10.1002/ijc.2910040205. [DOI] [PubMed] [Google Scholar]
- 12.Kanellos J, Pietersz GA, McKenzie FC. Studies of methotrexate monoclonal antibody conjugates for immunotherapy. J Natl Cancer Inst. 1985;75:319. [PubMed] [Google Scholar]
- 13.Kulkarni PN, Blair AH, Ghose TI. Covalent binding of methotrexate to immunoglobulins and the effect of antibody-linked drug on tumor growth in vivo. Cancer Res. 1981;41:2700. [PubMed] [Google Scholar]
- 14.Manabe Y, Tsubota T, Haruta Y, Kataoka K, Okazaki M, Haisa S, Nakamura K, Kimura I. Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biological activity. J Lab Clin Med. 1984;104:445. [PubMed] [Google Scholar]
- 15.Order SE, Klein JL, Leichner PK. Antiferritin IgG antibody for isotopic cancer therapy. Oncology. 1981;38:154. doi: 10.1159/000225543. [DOI] [PubMed] [Google Scholar]
- 16.Royston I, Majda JA, Baird SM, Meserve BL, Griffiths JC (1979) Monoclonal antibody specific for human T lymphocytes: identification of normal and malignant T cells. Blood 54 (Suppl 1): 106A
- 17.Seto M, Umemoto N, Saito M, Masuho Y, Hara T, Takahashi T. Monoclonal anti-MM46 antibody:ricin A chain conjugate: in vitro and in vivo antitumor activity. Cancer Res. 1982;42:5209. [PubMed] [Google Scholar]
- 18.Seto M, Takahashi T, Tanimoto M, Nishizuka Y. Production of monoclonal antibodies against MM antigens: the serologic identification of MM antigen with Ly-6.2 alloantigen. J Immunol. 1982;128:201. [PubMed] [Google Scholar]
- 19.Seto M, Takahashi T, Nakamura S, Matsudaira Y, Nishizuka Y. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res. 1983;43:4768. [PubMed] [Google Scholar]
- 20.Uadia P, Blair AH, Ghose T. Uptake of methotrexate linked to an anti-EL4-lymphoma antibody by EL4 cells. Cancer Immunol Immunother. 1983;16:127. doi: 10.1007/BF00199245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Uadia P, Blair AH, Ghose T, Ferrone S. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line. J Natl Cancer Inst. 1985;74:29. [PubMed] [Google Scholar]